Figure 1.
Rapamycin decreases lymphoproliferation. CBA-lprcg mice were randomized to treatment with rapamycin versus vehicle control. After 4 weeks of treatment a decrease in adenopathy is visually apparent.
Rapamycin decreases lymphoproliferation. CBA-lprcg mice were randomized to treatment with rapamycin versus vehicle control. After 4 weeks of treatment a decrease in adenopathy is visually apparent.
